Human Gene CYP21A2 (uc003nze.2)
  Description: Homo sapiens cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2), transcript variant 1, mRNA.
RefSeq Summary (NM_000500): This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].
Transcript (Including UTRs)
   Position: hg19 chr6:32,006,093-32,009,447 Size: 3,355 Total Exon Count: 10 Strand: +
Coding Region
   Position: hg19 chr6:32,006,200-32,008,911 Size: 2,712 Coding Exon Count: 10 

Page IndexSequence and LinksUniProtKB CommentsPrimersGenetic AssociationsMalaCards
CTDGene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein Structure
Other SpeciesGO AnnotationsmRNA DescriptionsPathwaysOther NamesGeneReviews
Model InformationMethods
Data last updated at UCSC: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr6:32,006,093-32,009,447)mRNA (may differ from genome)Protein (495 aa)
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaAlphaFold
BioGPSEnsemblEntrez GeneExonPrimerGeneCardsGeneNetwork
H-INVHGNCHPRDLynxMalacardsMGI
OMIMPubMedUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: Q16874_HUMAN
DESCRIPTION: SubName: Full=Cytochrome P450 21-hydroxylase; SubName: Full=Cytochrome P450, family 21, subfamily A, polypeptide 2; SubName: Full=Cytochrome P450, family 21, subfamily A, polypeptide 2, isoform CRA_b; SubName: Full=DJ34F7.3 (Cytochrome P450, subfamily XXIA (Steroid 21-hydroxylase, congenital adrenal hyperplasia), polypeptide 2 (CYP21, P450c21B)); SubName: Full=Steroid 21-hydroxylase; SubName: Full=cDNA, FLJ95495, Homo sapiens cytochrome P450, family 21, subfamily A, polypeptide 2(CYP21A2), mRNA;
SIMILARITY: Belongs to the cytochrome P450 family.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): CYP21A2
CDC HuGE Published Literature: CYP21A2
Positive Disease Associations: congenital adrenal hyperplasia , gestational age , hyperandrogenism , polycystic ovary syndrome; adrenal androgen
Related Studies:
  1. congenital adrenal hyperplasia
    Lobato MN et al. 1999, Mutation analysis in patients with congenital adrenal hyperplasia in the Spanish population: identification of putative novel steroid 21-hydroxylase deficiency alleles associated with the classic form of the disease., Human heredity. 1999 Jun;49(3):169-75. [PubMed 10364682]
  2. congenital adrenal hyperplasia
    Dolzan V 2003, Mutational spectrum of congenital adrenal hyperplasia in Slovenian patients: a novel Ala15Thr mutation and Pro30Leu within a larger gene conversion associated with a severe form of the disease., European journal of endocrinology. 2003 Aug;149(2):137-44. [PubMed 12887291]
    Our genotyping approach allowed reliable diagnosis of CAH in the Slovenian population. The high frequency of CYP21 gene aberrations on Pro30Leu positive alleles justified systematic searching for a gene conversion in the promoter region using the PCR-SSP reaction.
  3. gestational age
    Gidlof, S. et al. 2006, Gestational age correlates to genotype in girls with CYP21 deficiency, J Clin Endocrinol Metab 2006. [PubMed 17047018]
    Female patients with severe CYP21 deficiency had longer GA than patients with the milder form of the disease, indicating that androgen excess, increased 17-hydroxyprogesterone levels, or cortisol deficiency or a combination of these factors is of importance for prolongation of pregnancy. The same correlation was not observed for male patients. The results of this study support the notion that steroid hormones affect the prolongation of pregnancy or onset of labor or both.
           more ... click here to view the complete list

-  MalaCards Disease Associations
  MalaCards Gene Search: CYP21A2
Diseases sorted by gene-association score: adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency* (1300), classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form* (350), classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form* (350), congenital adrenal hyperplasia (54), luteoma (24), testicular leydig cell tumor (23), antley-bixler syndrome (21), adrenal rest tumor (21), steroid inherited metabolic disorder (21), classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency (20), autoimmune addison disease (18), autoimmune polyglandular syndrome type 3 (18), addison's disease (18), precocious puberty (17), hyperandrogenism (17), leydig cell tumor (16), adrenal insufficiency, congenital, with 46xy sex reversal, partial or complete (15), polycystic ovary syndrome (13), 3-beta-hydroxysteroid dehydrogenase deficiency (13), adrenal adenoma (13), acute adrenal insufficiency (13), autoimmune polyendocrine syndrome type 1 (11), adrenal carcinoma (11), cytochrome p450 oxidoreductase deficiency (11), cortisone reductase deficiency (10), adrenal gland hyperfunction (8), aldosterone-producing adenoma (8), alopecia universalis (7), transsexualism (7), conn's syndrome (7), adrenal cortical adenoma (7), adrenal cortical carcinoma (7), inherited metabolic disorder (7), sex differentiation disease (5), alopecia, androgenetic, 1 (5), henoch-schoenlein purpura (5), adrenal cortical hypofunction (4), osteogenesis imperfecta, type ii (4), pseudohyperkalemia, familial, 2, due to red cell leak (4), pituitary-dependent cushing's disease (3)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene
  • C055238 1-chloro-4-(2,2-dichloro-1-(4-chlorophenyl)ethenyl)-3-(methylsulfonyl)benzene
  • C032668 1-nitropyrene
  • C120129 2,2',3,4',5',6-hexachlorobiphenyl
  • C066841 2,3,7,8-tetrabromodibenzo-4-dioxin
  • C009828 2,4,5,2',5'-pentachlorobiphenyl
  • C004554 2,4,6-tribromophenol
  • C038964 2,6-dibromophenol
  • C032790 3,3',4,4',5,5'-hexabromobiphenyl
  • C036685 3,3',4,4'-tetrabromobiphenyl
  • C023035 3,4,5,3',4'-pentachlorobiphenyl
          more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 1061.06 RPKM in Adrenal Gland
Total median expression: 1101.55 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -43.90107-0.410 Picture PostScript Text
3' UTR -203.14536-0.379 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR001128 - Cyt_P450
IPR017972 - Cyt_P450_CS
IPR002401 - Cyt_P450_E_grp-I

Pfam Domains:
PF00067 - Cytochrome P450

SCOP Domains:
48264 - Cytochrome P450

ModBase Predicted Comparative 3D Structure on Q16874
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologGenome BrowserNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGD    
 Protein Sequence    
 Alignment    

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0004497 monooxygenase activity
GO:0005506 iron ion binding
GO:0016491 oxidoreductase activity
GO:0016705 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
GO:0020037 heme binding
GO:0046872 metal ion binding

Biological Process:
GO:0055114 oxidation-reduction process


-  Descriptions from all associated GenBank mRNAs
  JD419755 - Sequence 400779 from Patent EP1572962.
BC125181 - Homo sapiens cytochrome P450, family 21, subfamily A, polypeptide 2, mRNA (cDNA clone MGC:150536 IMAGE:40122017), complete cds.
BC125182 - Homo sapiens cytochrome P450, family 21, subfamily A, polypeptide 2, mRNA (cDNA clone MGC:150537 IMAGE:40122018), complete cds.
JD075662 - Sequence 56686 from Patent EP1572962.
JD359994 - Sequence 341018 from Patent EP1572962.
AK314651 - Homo sapiens cDNA, FLJ95495, Homo sapiens cytochrome P450, family 21, subfamily A, polypeptide 2(CYP21A2), mRNA.
JD355746 - Sequence 336770 from Patent EP1572962.
AK054616 - Homo sapiens cDNA FLJ30054 fis, clone ADRGL1000160, highly similar to CYTOCHROME P450 XXIB (EC 1.14.99.10).
JD151773 - Sequence 132797 from Patent EP1572962.
JD522936 - Sequence 503960 from Patent EP1572962.
AM086564 - Homo sapiens mRNA for steroid 21-hydroxylase, CYP21 (CYP21A2 gene) L166P allele.
AM086565 - Homo sapiens mRNA for steroid 21-hydroxylase, CYP21 (CYP21A2 gene), A391T allele.
AM183945 - Homo sapiens mRNA for steroid 21-hydroxylase, CYP21 (CYP21A2 gene), V139E allele.
AM183946 - Homo sapiens mRNA for steroid 21-hydroxylase, CYP21 (CYP21A2 gene), C147R allele.
AM183947 - Homo sapiens mRNA for steroid 21-hydroxylase, CYP21 (CYP21A2 gene), R233G allele.
AM183948 - Homo sapiens mRNA for steroid 21-hydroxylase, CYP21 (CYP21A2 gene), T295N allele.
AM183949 - Homo sapiens mRNA for steroid 21-hydroxylase, CYP21 (CYP21A2 gene), L308F allele.
AM183950 - Homo sapiens mRNA for steroid 21-hydroxylase, CYP21 (CYP21A2 gene), R366C allele.
AM183951 - Homo sapiens mRNA for steroid 21-hydroxylase, CYP21 (CYP21A2 gene), M473I allele.
M17252 - Human cytochrome P450c21 mRNA, 3' end.
KJ905723 - Synthetic construct Homo sapiens clone ccsbBroadEn_15393 CYP21A2 gene, encodes complete protein.
BC128535 - Homo sapiens cytochrome P450, family 21, subfamily A, polypeptide 2, mRNA (cDNA clone IMAGE:40120157), complete cds.
JD121385 - Sequence 102409 from Patent EP1572962.
JD474302 - Sequence 455326 from Patent EP1572962.
JD342602 - Sequence 323626 from Patent EP1572962.
CU689723 - Synthetic construct Homo sapiens gateway clone IMAGE:100020002 3' read TNXB mRNA.
JD402232 - Sequence 383256 from Patent EP1572962.
JD402233 - Sequence 383257 from Patent EP1572962.
JD077734 - Sequence 58758 from Patent EP1572962.
JD555695 - Sequence 536719 from Patent EP1572962.
JD186382 - Sequence 167406 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  KEGG - Kyoto Encyclopedia of Genes and Genomes
hsa00140 - Steroid hormone biosynthesis
hsa01100 - Metabolic pathways

-  Other Names for This Gene
  Alternate Gene Symbols: DADB-112B14.10-002, DAQB-124C11.2-002, hCG_1999926, NM_000500, NP_000491, P450-CYP21B, Q16874, Q16874_HUMAN
UCSC ID: uc003nze.2
RefSeq Accession: NM_000500
Protein: Q16874 CCDS: CCDS4735.1

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene CYP21A2:
cah (21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia)

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: NM_000500.7
exon count: 10CDS single in 3' UTR: no RNA size: 2131
ORF size: 1488CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 3152.00frame shift in genome: no % Coverage: 100.00
has start codon: yes stop codon in genome: no # of Alignments: 10
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.